SKP alleviates the ferroptosis in diabetic kidney disease through suppression of HIF-1α/HO-1 pathway based on network pharmacology analysis and experimental validation.
Yangtian YanNingning YuanYuchi ChenYun MaAli ChenFujing WangShihua YanZhuo'en HeJinyue HeChi ZhangHao WangMingqing WangJianxin DiaoWei XiaoPublished in: Chinese medicine (2024)
SKP potentially mitigating renal injury in DKD by subduing ferroptosis through the intricacies of the HIF-1α/HO-1 signaling pathway.